02095nas a2200469   4500000000100000008004100001260000900042653001500051653001000066653001600076653000900092653002200101653002600123653002400149653001100173653001000184653002100194653001100215653001600226653001100242653002100253653001200274653002000286653000900306653001600315653002500331653001700356653003000373653001600403653000900419653001600428100002000444700001600464700001600480700002200496700001600518245006500534300001000599490001500609520098700624022001401611       2008                            d  c200810aAdolescent10aAdult10aAge Factors10aAged10aAged, 80 and over10aAntibodies, Bacterial10aAntigens, Bacterial10aBrazil10aChild10aChild, Preschool10aFemale10aGlycolipids10aHumans10aImmunoglobulin M10aleprosy10aLogistic Models10aMale10aMiddle Aged10aMycobacterium leprae10aRisk Factors10aSeverity of Illness Index10aSex Factors10aSkin10aYoung Adult1 aFaria Grossi MA1 aLeboeuf MAA1 aAndrade ARC1 aBührer-Sékula S1 aAntunes CMF00aRisk factors for ML Flow seropositivity in leprosy patients.  a39-440 v41 Suppl 23 a<p>The early diagnosis of leprosy, its correct classification and the risk factors related to seropositivity have become important for patient treatment and disease control, especially where the responsibility for treatment has been transferred to basic health care centers. This descriptive, exploratory study using logistic regression was undertaken to evaluate the association between the variables of sex, age, mode of detection, number of skin lesions and affected nerves, disability grade and bacilloscopy with the results of the ML Flow serological test in 1,072 new leprosy cases in 13 municipalities in Minas Gerais State. Seropositivity (50.7%) was statistically associated with patients 15 years-old or over (OR:2.6) and those with more than five skin lesions (OR:7.5), more than one affected nerve (OR:2.4) and a positive bacilloscopic index (OR:5.5 for 0<BI<2 and OR:191.2 for BI>or=2), thus contributing to the appropriate classification and treatment of patients.</p>  a1678-9849